Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses Evaluating Omadacycline Dosing Regimens for the Treatment of Patients with Community-Acquired Bacterial Pneumonia Arising from Streptococcus pneumoniae and Haemophilus influenzae.
Bhavnani SM, Hammel JP, Lakota EA, Trang M, Bader JC, Bulik CC, VanScoy BD, Rubino CM, Huband MD, Friedrich L, Steenbergen JN, Ambrose PG. Bhavnani SM, et al. Among authors: trang m. Antimicrob Agents Chemother. 2023 Apr 18;67(4):e0221321. doi: 10.1128/aac.02213-21. Epub 2023 Mar 22. Antimicrob Agents Chemother. 2023. PMID: 36946741 Free PMC article. Clinical Trial.
Pharmacokinetics-Pharmacodynamics of CB-618 in Combination with Cefepime, Ceftazidime, Ceftolozane, or Meropenem: the Pharmacological Basis for a Stand-Alone β-Lactamase Inhibitor.
Ambrose PG, VanScoy BD, Trang M, McCauley-Miller J, Conde H, Bhavnani SM, Alexander DC, Friedrich LV. Ambrose PG, et al. Among authors: trang m. Antimicrob Agents Chemother. 2017 Nov 22;61(12):e00630-17. doi: 10.1128/AAC.00630-17. Print 2017 Dec. Antimicrob Agents Chemother. 2017. PMID: 28947474 Free PMC article.
Population Pharmacokinetic Analyses for Omadacycline Using Phase 1 and 3 Data.
Lakota EA, Van Wart SA, Trang M, Tzanis E, Bhavnani SM, Safir MC, Friedrich L, Steenbergen JN, Ambrose PG, Rubino CM. Lakota EA, et al. Among authors: trang m. Antimicrob Agents Chemother. 2020 Jun 23;64(7):e02263-19. doi: 10.1128/AAC.02263-19. Print 2020 Jun 23. Antimicrob Agents Chemother. 2020. PMID: 32340986 Free PMC article.
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses as Support for Meropenem-Vaborbactam Dosing Regimens and Susceptibility Breakpoints.
Bhavnani SM, Trang M, Griffith DC, Lomovskaya O, Hammel JP, Loutit JS, Cammarata SK, Dudley MN, Ambrose PG, Rubino CM. Bhavnani SM, et al. Among authors: trang m. Antimicrob Agents Chemother. 2022 Dec 20;66(12):e0213021. doi: 10.1128/aac.02130-21. Epub 2022 Nov 14. Antimicrob Agents Chemother. 2022. PMID: 36374023 Free PMC article.
Evaluation of the Impact of Comorbidities on Omadacycline Pharmacokinetics.
Trang M, Lakota EA, Safir MC, Bhavnani SM, Friedrich L, Steenbergen JN, McGovern PC, Tzanis E, Rubino CM. Trang M, et al. Antimicrob Agents Chemother. 2023 Apr 18;67(4):e0239721. doi: 10.1128/aac.02397-21. Epub 2023 Mar 14. Antimicrob Agents Chemother. 2023. PMID: 36916956 Free PMC article.
17 results